Fast-GCaMP-EF05
(Plasmid
#52558)
-
Purposegenetically encodable fluorescent calcium indicator protein to monitor neuronal activity
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 52558 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepJFRC-MUH
-
Backbone manufacturerAddgene
- Backbone size w/o insert (bp) 7831
- Total vector size (bp) 9184
-
Modifications to backboneinsert between BglII and NotI
-
Vector typeInsect Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFast-GCaMP-EF05
-
SpeciesH. sapiens (human), Synthetic
-
Insert Size (bp)1353
-
Mutationchanged from GCaMP3: D397N/G398A/N399D
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer TACT AGATCT GCCGCCACC atgggttctcatcatcat
- 3′ sequencing primer att cca cca ctg ctc cca (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byAddgene 26213
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Fast-GCaMP-EF05 was a gift from Samuel Wang (Addgene plasmid # 52558 ; http://n2t.net/addgene:52558 ; RRID:Addgene_52558) -
For your References section:
Fast GCaMPs for improved tracking of neuronal activity. Sun XR, Badura A, Pacheco DA, Lynch LA, Schneider ER, Taylor MP, Hogue IB, Enquist LW, Murthy M, Wang SS. Nat Commun. 2013 Jul 17;4:2170. doi: 10.1038/ncomms3170. 10.1038/ncomms3170 PubMed 23863808